Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acetylsalicylic Acid Lysinate
2. Aspegic
3. Aspirin Lysinate
4. Aspirin Lysine
5. Aspiryl-polylysine
6. Aspisol
7. Asprin Dl-lysine
8. Flectadol
9. L-lysine, 2-(acetyloxy)benzoate (1:1)
10. Lysine Acetylsalicylate
11. Lysine-acetylsalicylic Acid
12. Lysine-aspirin
13. Solusprin
14. Solusprin, Monosalicylate, (dl-lys)-isomer
15. Solusprin, Monosalicylate, (l-lys)-isomer
16. Venopirin
1. Dl-lysine Acetylsalicylate
2. 62952-06-1
3. Aspegic
4. Egicalm
5. Aspirisine
6. Aspidol
7. Solpirin
8. Venopirin
9. Vetalgine
10. Dl-lysine-acetylsalicylate
11. Flectadol
12. Laspal
13. L-lysine Acetylsalicylate
14. Lysine Acetylsalicylic Acid
15. Asl
16. Lysine Acetylsalicylate,(s)
17. Schembl25877
18. 2-acetoxybenzoic Acid (1:1)
19. Lysine Aspirin [mart.]
20. Chembl1697753
21. Dtxsid50886518
22. Bcp12010
23. Lysine Acetylsalicylate [mi]
24. Akos025402349
25. 2,6-diaminohexanoic Acid Compound With
26. Ac-8243
27. Dl-lysine Acetylsalicylate, Aldrichcpr
28. Acetylsalicylate Lysine [who-dd]
29. Ft-0670894
30. Dl-lysine Acetylsalicylate [ep Monograph]
31. 952l061
32. Q15041214
Molecular Weight | 326.34 g/mol |
---|---|
Molecular Formula | C15H22N2O6 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 8 |
Exact Mass | 326.14778643 g/mol |
Monoisotopic Mass | 326.14778643 g/mol |
Topological Polar Surface Area | 153 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 318 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
M2i Group, an integrated CDMO, is your French partner for development & manufacturing in fine chemistry.
Product Not Available For Sales
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8468
Submission : 1990-03-12
Status : Inactive
Type : II
Global Sales Information
Market Place
ABOUT THIS PAGE
39
PharmaCompass offers a list of Aspirin Lysinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aspirin Lysinate manufacturer or Aspirin Lysinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aspirin Lysinate manufacturer or Aspirin Lysinate supplier.
PharmaCompass also assists you with knowing the Aspirin Lysinate API Price utilized in the formulation of products. Aspirin Lysinate API Price is not always fixed or binding as the Aspirin Lysinate Price is obtained through a variety of data sources. The Aspirin Lysinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH], including repackagers and relabelers. The FDA regulates DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] supplier is an individual or a company that provides DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] active pharmaceutical ingredient (API) or DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] finished formulations upon request. The DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] suppliers may include DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] API manufacturers, exporters, distributors and traders.
click here to find a list of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] DMF (Drug Master File) is a document detailing the whole manufacturing process of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] active pharmaceutical ingredient (API) in detail. Different forms of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] DMFs exist exist since differing nations have different regulations, such as DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] DMF submitted to regulatory agencies in the US is known as a USDMF. DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] USDMF includes data on DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] suppliers with USDMF on PharmaCompass.
DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] GMP manufacturer or DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] GMP API supplier for your needs.
A DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] CoA (Certificate of Analysis) is a formal document that attests to DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH]'s compliance with DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] specifications and serves as a tool for batch-level quality control.
DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] CoA mostly includes findings from lab analyses of a specific batch. For each DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] may be tested according to a variety of international standards, such as European Pharmacopoeia (DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] EP), DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DL-LYSINE ACETYLSALICYLATE [EP MONOGRAPH] USP).